{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:23:43Z","timestamp":1792783423495,"version":"4.5.0"},"reference-count":148,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2017,4,12]],"date-time":"2017-04-12T00:00:00Z","timestamp":1491955200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Science and Technology Department of People's Republic of China","award":["No. 2012ZX09303-001"],"award-info":[{"award-number":["No. 2012ZX09303-001"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hepatol Int"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1007\/s12072-017-9793-2","type":"journal-article","created":{"date-parts":[[2017,4,12]],"date-time":"2017-04-12T04:38:52Z","timestamp":1491971932000},"page":"221-241","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":253,"title":["CSH guidelines for the diagnosis and treatment of drug-induced liver injury"],"prefix":"10.1007","volume":"11","author":[{"name":"Drug-induced Liver Injury (DILI) Study Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3480-1829","authenticated-orcid":false,"given":"Yue-cheng","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Chinese Society of Hepatology (CSH)","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Chinese Medical Association (CMA)","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-min","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-wei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-jun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-ming","family":"Cong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhong-ping","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing-chun","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-yan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi-qi","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-dong","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong-tao","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-liang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-xia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lun-gen","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-wu","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue-min","family":"Nan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-yao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tai-ling","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-jin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lai","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-qing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-liang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-yan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min-de","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-yan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,4,12]]},"reference":[{"issue":"7","key":"9793_CR1","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1053\/j.gastro.2013.02.006","volume":"144","author":"ES Bj\u00f6rnsson","year":"2013","unstructured":"Bj\u00f6rnsson ES, Bergmann OM, Bj\u00f6rnsson HK, et al. Incidence, presentation, and outcomes in patients with drug-induced liver injury in the general population of Iceland. Gastroenterology. 2013;144(7):1419\u20131425","journal-title":"Gastroenterology"},{"issue":"1","key":"9793_CR2","doi-asserted-by":"publisher","first-page":"55","DOI":"10.2165\/00002018-200932010-00005","volume":"32","author":"RJ Fontana","year":"2009","unstructured":"Fontana RJ, Watkins PB, Bonkovsky HL, et al. Drug-induced liver injury network (DILIN) prospective study: rationale, design and conduct. Drug Saf. 2009;32(1):55\u201368","journal-title":"Drug Saf"},{"issue":"7","key":"9793_CR3","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1038\/ajg.2014.131","volume":"109","author":"NP Chalasani","year":"2014","unstructured":"Chalasani NP, Hayashi PH, Bonkovsky HL, et al. ACG Clinical Guide: the diagnosis and management of idiosyncratic drug-induced liver injury. Am J Gastroenterol. 2014;109(7):950\u2013966","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"9793_CR4","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.jceh.2012.05.002","volume":"2","author":"H Devarbhavi","year":"2012","unstructured":"Devarbhavi H. An\u00a0update\u00a0on\u00a0drug\u2014induced liver injury. J Clin Exp Hepatol. 2012;2(3):247\u2013259","journal-title":"J Clin Exp Hepatol"},{"issue":"7","key":"9793_CR5","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1038\/ajg.2016.114","volume":"111","author":"L Hillman","year":"2016","unstructured":"Hillman L, Gottfried M, Whitsett M, et al. Clinical features and outcomes of complementary and alternative medicine induced acute liver failure and injury. Am J Gastroenterol. 2016;111(7):958\u2013965","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"9793_CR6","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.1053\/j.gastro.2008.09.011","volume":"135","author":"N Chalasani","year":"2008","unstructured":"Chalasani N, Fontana RJ, Bonkovsky HL, et al. Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States. Gastroenterology. 2008;135(6):1924\u20131934","journal-title":"Gastroenterology"},{"issue":"6","key":"9793_CR7","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1002\/hep.23937","volume":"52","author":"A Reuben","year":"2010","unstructured":"Reuben A, Koch DG, Lee WM. Drug-induced acute liver failure: results of a U.S. multicenter, prospective study. Hepatology. 2010;52(6):2065\u20132076","journal-title":"Hepatology"},{"issue":"11","key":"9793_CR8","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1002\/pds.3309","volume":"21","author":"A Miguel","year":"2012","unstructured":"Miguel A, Azevedo LF, Ara\u00fajo M, Pereira AC. Frequency of adverse drug reactions in hospitalized patients: a systematic review and meta-analysis. Pharmacoepidemiol Drug Saf. 2012;21(11):1139\u20131154","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"1","key":"9793_CR9","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1007\/s11684-007-0012-8","volume":"1","author":"L Li","year":"2007","unstructured":"Li L, Jiang W, Wang JY. Clinical analysis of 275 cases of acute drug-induced liver disease. Front Med China. 2007;1(1):58\u201361","journal-title":"Front Med China"},{"issue":"3","key":"9793_CR10","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1002\/hep.26175","volume":"57","author":"JH Hoofnagle","year":"2013","unstructured":"Hoofnagle JH, Serrano J, Knoben JE, et al. LiverTox: a website on drug-induced liver injury. Hepatology. 2013;57(3):873\u2013874","journal-title":"Hepatology"},{"key":"9793_CR11","unstructured":"Yimin M. HepaTox: The professional networking platform for promoting clinical and translational research of drug-induced liver injury in China. Chin Hepatol 2014;(8):575\u2013576 (article in Chinese)"},{"issue":"2","key":"9793_CR12","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1055\/s-2002-30101","volume":"22","author":"D Larrey","year":"2002","unstructured":"Larrey D. Epidemiology and individual susceptibility to adverse drug reactions affecting the liver. Semin Liver Dis. 2002;22(2):145\u2013155","journal-title":"Semin Liver Dis"},{"issue":"2","key":"9793_CR13","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1055\/s-0034-1375953","volume":"34","author":"ES Bjornsson","year":"2014","unstructured":"Bjornsson ES. Epidemiology and risk factors for idiosyncratic drug-induced liver injury. Semin Liver Dis. 2014;34(2):115\u2013122","journal-title":"Semin Liver Dis"},{"key":"9793_CR14","unstructured":"Lai RT, Wang H, Gui HL, et al. Clinical and pathological features in 138 cases of drug-induced liver injury. Chin J Hepatol 2012;20(3):185\u2013189 (article in Chinese)"},{"key":"9793_CR15","unstructured":"Hao KY, Yu YC, He CL, et al. Analysis on the diagnosis, clinical features and prognosis of 140 cases with drug-induced liver injury based on the RUCAM scales. Chin J Hepatol 2014;22(12):82\u201385 (article in Chinese)"},{"issue":"8","key":"9793_CR16","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1002\/lt.20204","volume":"10","author":"MW Russo","year":"2004","unstructured":"Russo MW, Galanko JA, Shrestha R, et al. Liver transplantation for acute liver failure from drug induced liver injury in the United States. Liver Transpl. 2004;10(8):1018\u20131023","journal-title":"Liver Transpl"},{"issue":"9","key":"9793_CR17","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1080\/00365520510023846","volume":"40","author":"E Bjornsson","year":"2005","unstructured":"Bjornsson E, Jerlstad P, Bergqvist A, et al. Fulminant drug-induced hepatic failure leading to death or liver transplantation in Sweden. Scand J Gastroenterol. 2005;40(9):1095\u20131101","journal-title":"Scand J Gastroenterol"},{"issue":"2","key":"9793_CR18","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s12013-012-9373-y","volume":"64","author":"FQ Hou","year":"2012","unstructured":"Hou FQ, Zeng Z, Wang GQ. Hospital admissions for drug-induced liver injury: clinical features, therapy, and outcomes. Cell Biochem Biophys. 2012;64(2):77\u201383","journal-title":"Cell Biochem Biophys"},{"issue":"7","key":"9793_CR19","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1517\/17425255.2011.577415","volume":"7","author":"JG Stine","year":"2011","unstructured":"Stine JG, Lewis JH. Drug-induced liver injury: a summary of recent advances. Expert Opin Drug Metab Toxicol. 2011;7(7):875\u2013890","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"7","key":"9793_CR20","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1053\/j.gastro.2013.04.026","volume":"144","author":"JH Hoofnagle","year":"2013","unstructured":"Hoofnagle JH, Navarro VJ. Drug-induced liver injury: Icelandic lessons. Gastroenterology. 2013;144(7):1335\u20131336","journal-title":"Gastroenterology"},{"issue":"6","key":"9793_CR21","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1002\/hep.22895","volume":"49","author":"MI Lucena","year":"2009","unstructured":"Lucena MI, Andrade RJ, Kaplowitz N, et al. Phenotypic characterization of idiosyncratic drug-induced liver injury: the influence of age and sex. Hepatology. 2009;49(6):2001\u20132009","journal-title":"Hepatology"},{"issue":"4","key":"9793_CR22","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.jhep.2007.06.016","volume":"47","author":"E Elinav","year":"2007","unstructured":"Elinav E, Pinsker G, Safadi R, et al. Association between consumption of Herbalife nutritional supplements and acute hepatotoxicity. J Hepatol. 2007;47(4):514\u2013520","journal-title":"J Hepatol"},{"key":"9793_CR23","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1530\/EJE-10-1030","volume":"164","author":"F Azizi","year":"2011","unstructured":"Azizi F, Amouzegar A. Management of hyperthyroidism during pregnancy and lactation. Eur J Endocrinol. 2011;164:871\u2013876","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"9793_CR24","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.cgh.2014.07.054","volume":"13","author":"MA Martinez","year":"2015","unstructured":"Martinez MA, Vuppalanchi R, Fontana RJ, et al. Clinical and histologic features of azithromycin-induced liver injury. Clin Gastroenterol Hepatol. 2015;13(2):369\u2013376","journal-title":"Clin Gastroenterol Hepatol"},{"key":"9793_CR25","doi-asserted-by":"publisher","first-page":"703","DOI":"10.2147\/IJGM.S49657","volume":"6","author":"T Saadi","year":"2013","unstructured":"Saadi T, Waterman M, Yassin H, et al. Metformin-induced\u00a0mixed hepatocellular and cholestatic hepatic\u00a0injury: case report and literature review. Int J Gen Med. 2013;6:703\u2013706","journal-title":"Int J Gen Med"},{"issue":"1","key":"9793_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/QAD.0b013e3282f0e2fd","volume":"22","author":"V Soriano","year":"2008","unstructured":"Soriano V, Puoti M, Garcia-Gasco P, et al. Antiretroviral drugs and liver injury. AIDS. 2008;22(1):1\u201313","journal-title":"AIDS"},{"issue":"1","key":"9793_CR27","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.cld.2013.09.015","volume":"18","author":"R Pais","year":"2014","unstructured":"Pais R, Rusu E, Ratziu V. The impact of\u00a0obesity\u00a0and metabolic syndrome on chronic hepatitis B and\u00a0drug-induced\u00a0liver\u00a0disease. Clin Liver Dis. 2014;18(1):165\u2013178","journal-title":"Clin Liver Dis"},{"issue":"6","key":"9793_CR28","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1002\/hep.21424","volume":"44","author":"RJ Andrade","year":"2006","unstructured":"Andrade RJ, Lucena MI, Kaplowitz N, et al. Outcome of acute idiosyncratic drug-induced liver injury: long-term follow-up in a hepatotoxicity registry. Hepatology. 2006;44(6):1581\u20131588","journal-title":"Hepatology"},{"key":"9793_CR29","doi-asserted-by":"crossref","unstructured":"Sharma SK1,\u00a0Balamurugan A,\u00a0Saha PK,\u00a0et al. Evaluation of clinical and immunogenetic risk factors for the development of hepatotoxicity during antituberculosis treatment. Am J Respir Crit Care Med\u00a02002;166(7):916\u2013919","DOI":"10.1164\/rccm.2108091"},{"key":"9793_CR30","unstructured":"Pukenyte E,\u00a0Lescure FX,\u00a0Rey D,\u00a0et al. Incidence of and risk factors for severe liver toxicity in HIV-infected patients on anti-tuberculosis treatment. Int J Tuberc Lung Dis 2007;11(1):78\u201384"},{"issue":"2","key":"9793_CR31","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1378\/chest.68.2.181","volume":"68","author":"JR Mitchell","year":"1975","unstructured":"Mitchell JR, Long MW, Thorgeirsson UP, et al. Acetylation rates and monthly liverfunction tests during one year of isoniazid preventive therapy. Chest. 1975;68(2):181\u2013190","journal-title":"Chest"},{"issue":"2","key":"9793_CR32","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1002\/hep.510290241","volume":"29","author":"RM Shayiq","year":"1999","unstructured":"Shayiq RM, Roberts DW, Rothstein K, et al. Repeat exposure to incremental doses of acetaminophen provides protection against acetaminophen-induced lethality in mice: an explanation for high acetaminophen dosage in humans without hepatic injury. Hepatology. 1999;29(2):451\u2013463","journal-title":"Hepatology"},{"issue":"13","key":"9793_CR33","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1001\/jama.1994.03510370044030","volume":"271","author":"PB Watkins","year":"1994","unstructured":"Watkins PB, Zimmerman HJ, Knapp MJ, et al. Hepatotoxic effects of tacrine administration in patients with Alzheimer\u2019s disease. JAMA. 1994;271(13):992\u2013998","journal-title":"JAMA"},{"key":"9793_CR34","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1097\/HCO.0b013e328347036f","volume":"26","author":"PJ Zamor","year":"2011","unstructured":"Zamor PJ, Russo MW. Liver function tests and statins. Curr Opin Cardiol. 2011;26:338\u2013341","journal-title":"Curr Opin Cardiol"},{"issue":"4","key":"9793_CR35","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1002\/hep.24229","volume":"53","author":"MS Padda","year":"2011","unstructured":"Padda MS, Sanchez M, Akhtar AJ, Boyer JL. Drug-induced cholestasis. Hepatology. 2011;53(4):1377\u20131387","journal-title":"Hepatology"},{"issue":"2","key":"9793_CR36","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1002\/hep.24060","volume":"53","author":"N Khandelwal","year":"2011","unstructured":"Khandelwal N, James LP, Sanders C, et al. Unrecognized acetaminophen toxicity as a cause of indeterminate acute liver failure. Hepatology. 2011;53(2):567\u2013576","journal-title":"Hepatology"},{"key":"9793_CR37","doi-asserted-by":"publisher","unstructured":"Guengerich\u00a0FP.\u00a0Cytochrome\u00a0P450\u00a0Activation\u00a0of\u00a0Toxins\u00a0and\u00a0Hepatotoxicity.\u00a0In\u00a0Kaplowitz\u00a0N,\u00a0DeLeve\u00a0LD.\u00a0Drug\u00a0Induced\u00a0Liver\u00a0Disease,\u00a03rd\u00a0ed.\u00a0New York: Elsevier; 2013. 15\u201333","DOI":"10.1016\/B978-0-12-387817-5.00002-9"},{"issue":"1","key":"9793_CR38","doi-asserted-by":"publisher","first-page":"116","DOI":"10.3109\/03602532.2011.605790","volume":"44","author":"AK Daly","year":"2012","unstructured":"Daly AK, Day CP. Genetic association studies in drug-induced liver injury. Drug Metab Rev. 2012;44(1):116\u2013126","journal-title":"Drug Metab Rev"},{"issue":"2","key":"9793_CR39","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1002\/hep.23720","volume":"52","author":"S Russmann","year":"2010","unstructured":"Russmann S, Jetter A, Kullak-Ublick GA. Pharmacogenetics of drug-induced liver injury. Hepatology. 2010;52(2):748\u2013761","journal-title":"Hepatology"},{"issue":"R1","key":"9793_CR40","doi-asserted-by":"publisher","first-page":"R58","DOI":"10.1093\/hmg\/dds341","volume":"21","author":"CY Wei","year":"2012","unstructured":"Wei CY, Lee MTM, Chen YT. Pharmacogenomics of adverse drug reactions: implementing personalized medicine. Hum Mol Genet. 2012;21(R1):R58\u2013R65","journal-title":"Hum Mol Genet"},{"issue":"6","key":"9793_CR41","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/gm350","volume":"4","author":"A Alfirevic","year":"2012","unstructured":"Alfirevic A, Gonzalez-Galarza F, Bell C, et al. In silico analysis of HLA associations with drug-induced liver injury use of a HLA-genotyped DNA archive from healthy volunteers. Genome Med. 2012;4(6):51","journal-title":"Genome Med"},{"issue":"3","key":"9793_CR42","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1038\/sj.tpj.6500458","volume":"8","author":"A Kindmark","year":"2008","unstructured":"Kindmark A, Jawaid A, Harbron CG, et al. Genome-wide pharmacogenetic investigation of a hepatic adverse event without clinical signs of immunopathology suggests an underlying immune pathogenesis. Pharmacogenom J. 2008;8(3):186\u2013195","journal-title":"Pharmacogenom J"},{"issue":"8","key":"9793_CR43","first-page":"711","volume":"42","author":"JB Singer","year":"2010","unstructured":"Singer JB, Lewitzky S, Leroy E, Yang F, Zhao X, Klickstein L, et al. A genome-wide study identifies HLA alleles associated with lumiracoxib-related liver injury. Nature. 2010;42(8):711\u2013714","journal-title":"Nature"},{"issue":"1","key":"9793_CR44","doi-asserted-by":"publisher","first-page":"34","DOI":"10.3109\/03602532.2011.604086","volume":"44","author":"D Pessayre","year":"2012","unstructured":"Pessayre D, Fromenty B, Berson A, et al. Central role of mitochondria in drug-induced liver injury. Drug Metab Rev. 2012;44(1):34\u201387","journal-title":"Drug Metab Rev"},{"key":"9793_CR45","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/j.redox.2014.07.003","volume":"2","author":"RL Goncalves","year":"2014","unstructured":"Goncalves RL, Rothschild DE, Quinlan CL, et al. Sources of superoxide\/H2O2 during mitochondrial proline oxidation. Redox Biol. 2014;2:901\u2013909","journal-title":"Redox Biol"},{"key":"9793_CR46","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1083\/jcb.201102095","volume":"194","author":"T Finkel","year":"2011","unstructured":"Finkel T. Signal transduction by reactive oxygen species. J Cell Biol. 2011;194:7\u201315","journal-title":"J Cell Biol"},{"key":"9793_CR47","doi-asserted-by":"publisher","first-page":"2837","DOI":"10.1089\/ars.2010.3713","volume":"15","author":"A Choumar","year":"2011","unstructured":"Choumar A, Tarhuni A, Letteron P, et al. Lipopolysaccharide-induced mitochondrial DNA depletion. Antioxid Redox Signal. 2011;15:2837\u20132854","journal-title":"Antioxid Redox Signal"},{"issue":"6","key":"9793_CR48","doi-asserted-by":"publisher","first-page":"527","DOI":"10.2174\/1566524033479564","volume":"3","author":"JS Kim","year":"2003","unstructured":"Kim JS, He L, Qian T, et al. Role of the mitochondrial permeability transition in apoptotic and necrotic death after ischemia\/reperfusion injury to hepatocytes. Curr Mol Med. 2003;3(6):527\u2013535","journal-title":"Curr Mol Med"},{"key":"9793_CR49","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1053\/j.gastro.2008.07.006","volume":"135","author":"H Nakagawa","year":"2008","unstructured":"Nakagawa H, Maeda S, Hikiba Y, et al. Deletion of apoptosis signal-regulating kinase 1 attenuates acetaminophen-induced liver injury by inhibiting c-Jun N-terminal kinase activation. Gastroenterology. 2008;135:1311\u20131321","journal-title":"Gastroenterology"},{"issue":"17\u201318","key":"9793_CR50","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/j.lfs.2011.01.025","volume":"88","author":"H Jaeschke","year":"2011","unstructured":"Jaeschke H, McGill MR, Williams CD, et al. Current issues with acetaminophen hepatotoxicity\u2014a clinically relevant model to test the efficacy of natural products. Life Sci. 2011;88(17\u201318):737\u2013745","journal-title":"Life Sci"},{"key":"9793_CR51","doi-asserted-by":"publisher","unstructured":"Martin-Murphy BV, Holt MP, Ju C. The role of damage associated molecular pattern molecules in acetaminophen induced liver injury in mice. Toxicol Lett 2010;192(3):387\u2013394","DOI":"10.1016\/j.toxlet.2009.11.016"},{"issue":"10","key":"9793_CR52","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1038\/ni.2991","volume":"15","author":"S Janssens","year":"2014","unstructured":"Janssens S, Pulendran B, Lambrecht BN. Emerging functions of the\u00a0unfolded protein response\u00a0in immunity. Nat Immunol. 2014;15(10):910\u2013919","journal-title":"Nat Immunol"},{"issue":"5","key":"9793_CR53","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1002\/hep.24279","volume":"55","author":"L Dara","year":"2011","unstructured":"Dara L, Ji C, Neil Kaplowitz N. The contribution of endoplasmic reticulum stress to liver diseases. Hepatology. 2011;55(5):1752\u20131763","journal-title":"Hepatology"},{"issue":"1","key":"9793_CR54","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1093\/toxsci\/kfu072","volume":"140","author":"L Fredriksson","year":"2014","unstructured":"Fredriksson L, Wink S, Herpers B, et al. Drug-induced\u00a0endoplasmic\u00a0reticulum\u00a0and oxidative stress responses independently sensitize toward TNF\u03b1-mediated hepatotoxicity. Toxicol Sci. 2014;140(1):144\u2013159","journal-title":"Toxicol Sci"},{"issue":"1","key":"9793_CR55","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.jhep.2015.02.004","volume":"63","author":"R Lai","year":"2015","unstructured":"Lai R, Xiang X, Mo R, et al. Protective effect of Th22 cells and intrahepatic IL-22 in drug induced\u00a0hepatocellular injury. J Hepatol. 2015;63(1):148\u2013155","journal-title":"J Hepatol"},{"key":"9793_CR56","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/978-3-642-00663-0_8","volume":"196","author":"MJ Masson","year":"2010","unstructured":"Masson MJ, Collins LA, Pohl LR. The role of cytokines in the mechanism of adverse drug reactions. Handb Exp Pharmacol. 2010;196:195\u2013231","journal-title":"Handb Exp Pharmacol"},{"issue":"4","key":"9793_CR57","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1055\/s-0029-1240007","volume":"29","author":"J Uetrecht","year":"2009","unstructured":"Uetrecht J. Immunoallergic drug-induced liver injury in humans. Semin Liver Dis. 2009;29(4):383\u2013392","journal-title":"Semin Liver Dis"},{"issue":"10","key":"9793_CR58","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1038\/nrm2970","volume":"11","author":"P Vandenabeele","year":"2010","unstructured":"Vandenabeele P, Galluzzi L, Vanden Berghe T, et al. Molecular mechanisms of necroptosis: an ordered cellular explosion. Nat Rev Mol Cell Biol. 2010;11(10):700\u2013714","journal-title":"Nat Rev Mol Cell Biol"},{"key":"9793_CR59","doi-asserted-by":"publisher","unstructured":"Ke PY,\u00a0Chen SS. Hepatitis\u00a0C virus and cellular\u00a0stress\u00a0response: implications to molecular pathogenesis of liver diseases. Viruses\u00a02012;4(10):2251\u20132290","DOI":"10.3390\/v4102251"},{"issue":"4","key":"9793_CR60","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1055\/s-0033-1358522","volume":"33","author":"A Henkel","year":"2013","unstructured":"Henkel A, Green RM. The unfolded protein response in fatty liver disease. Semin Liver Dis. 2013;33(4):321\u2013329","journal-title":"Semin Liver Dis"},{"issue":"4","key":"9793_CR61","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1053\/j.gastro.2013.12.032","volume":"146","author":"RJ Fontana","year":"2014","unstructured":"Fontana RJ. Pathogenesis of idiosyncratic drug-induced liver injury and clinical perspectives. Gastroenterology. 2014;146(4):914\u2013928","journal-title":"Gastroenterology"},{"issue":"1","key":"9793_CR62","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1517\/14740338.2013.828032","volume":"13","author":"SH Hussaini","year":"2014","unstructured":"Hussaini SH, Farrington EA. Idiosyncratic drug-induced liver injury: an update on the 2007 overview. Expert Opin Drug Saf. 2014;13(1):67\u201381","journal-title":"Expert Opin Drug Saf"},{"issue":"1","key":"9793_CR63","doi-asserted-by":"publisher","first-page":"107","DOI":"10.3109\/03602532.2011.645579","volume":"44","author":"C Ju","year":"2012","unstructured":"Ju C, Reilly T. Role of immune reactions in drug-induced liver injury (DILI). Drug Metab Rev. 2012;44(1):107\u2013115","journal-title":"Drug Metab Rev"},{"issue":"4","key":"9793_CR64","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1007\/s10620-011-1611-4","volume":"56","author":"AJ Czaja","year":"2011","unstructured":"Czaja AJ. Drug-induced autoimmune-like hepatitis. Dig Dis Sci. 2011;56(4):958\u2013976","journal-title":"Dig Dis Sci"},{"issue":"7","key":"9793_CR65","doi-asserted-by":"publisher","first-page":"2246","DOI":"10.1053\/j.gastro.2010.04.001","volume":"138","author":"N Chalasani","year":"2010","unstructured":"Chalasani N, Bj\u00f6rnsson E. Risk factors for idiosyncratic drug-induced liver injury. Gastroenterology. 2010;138(7):2246\u20132259","journal-title":"Gastroenterology"},{"key":"9793_CR66","doi-asserted-by":"publisher","unstructured":"Eisenberg-Lerner A, Kimchi A. PKD is a kinase of Vsp34 that mediates ROS-induced autophagy downstream of DAPk. Cell Death Differ 2012;19:788\u2013797","DOI":"10.1038\/cdd.2011.149"},{"key":"9793_CR67","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1258\/ebm.2011.010360","volume":"236","author":"WX Ding","year":"2011","unstructured":"Ding WX, Manley S, Ni HM. The emerging role of autophagy in alcoholic liver disease. Exp Biol Med. 2011;236:546\u2013556","journal-title":"Exp Biol Med"},{"key":"9793_CR68","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/B978-0-12-387817-5.00010-8","volume-title":"Drug-Induced Liver Disease","author":"RA Roth","year":"2013","unstructured":"Roth RA, Ganey PE. Role of inflammation in drug-induced liver injury. In: Kaplowitz N, Deleve LD, editors. Drug-Induced Liver Disease. 3rd ed. San Diego: Academic Press; 2013. 157\u2013173","edition":"3"},{"issue":"4","key":"9793_CR69","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s11684-010-0600-x","volume":"4","author":"MH Wu","year":"2010","unstructured":"Wu MH, Zang P, Huang X. Toll-like receptors in innate immunity and infectious diseases. Front Med China. 2010;4(4):385\u2013393","journal-title":"Front Med China"},{"issue":"9","key":"9793_CR70","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1016\/j.dci.2011.01.008","volume":"35","author":"JD Hansen","year":"2011","unstructured":"Hansen JD, Vojtech LN, Laing KJ. Sensing disease and danger: a survey of vertebrate PRRs and their origins. Dev Comp Immunol. 2011;35(9):886\u2013897","journal-title":"Dev Comp Immunol"},{"issue":"6","key":"9793_CR71","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1038\/nrd1750","volume":"4","author":"N Kaplowitz","year":"2005","unstructured":"Kaplowitz N. Idiosyncratic drug hepatotoxicity. Nat Rev Drug Discov. 2005;4(6):489\u2013499","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"9793_CR72","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1080\/01926230590881808","volume":"33","author":"HM Mehendale","year":"2005","unstructured":"Mehendale HM. Tissue repair: an important determinant of final outcome of toxicant-induced injury. Toxicol Pathol. 2005;33(1):41\u201351","journal-title":"Toxicol Pathol"},{"key":"9793_CR73","doi-asserted-by":"publisher","unstructured":"Kleiner DE. Histopathological Evaluation of Drug-Induced Liver Disease. In Kaplowttz N, DeLeve LD, ed. Drug-induced Liver Disease, 3rd ed. New York, Academic Press; 2013. 241\u2013261","DOI":"10.1016\/B978-0-12-387817-5.00015-7"},{"issue":"2","key":"9793_CR74","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/S1089-3261(02)00011-9","volume":"6","author":"ZD Goodman","year":"2002","unstructured":"Goodman ZD. Drug hepatotosicity. Clin Liver Dis. 2002;6(2):381\u2013397","journal-title":"Clin Liver Dis"},{"issue":"6","key":"9793_CR75","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1136\/jcp.2008.058248","volume":"62","author":"R Ramachandran","year":"2009","unstructured":"Ramachandran R, Kakar S. Histological patterns in drug-induced liver disease. J Clin Pathol. 2009;62(6):481\u2013492","journal-title":"J Clin Pathol"},{"issue":"4","key":"9793_CR76","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1055\/s-0029-1240005","volume":"29","author":"DE Kleiner","year":"2009","unstructured":"Kleiner DE. The pathology of drug-induced liver injury. Semin Liver Dis. 2009;29(4):364\u2013372","journal-title":"Semin Liver Dis"},{"issue":"4","key":"9793_CR77","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1111\/j.1472-8206.2008.00608.x","volume":"22","author":"G Labbe","year":"2008","unstructured":"Labbe G, Pessayre D, Fromenty B. Drug-induced liver injury through mitochondrial dysfunction: mechanisms and detection during preclinical safety studies. Fundam Clin Pharmacol. 2008;22(4):335\u2013353","journal-title":"Fundam Clin Pharmacol"},{"issue":"3","key":"9793_CR78","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1517\/17425255.3.3.407","volume":"3","author":"W Tang","year":"2007","unstructured":"Tang W. Drug metabolite profiling and elucidation of drug induced hepatotoxicity. Expert Opin Drug Metab Toxicol. 2007;3(3):407\u2013420","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"2","key":"9793_CR79","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1055\/s-0034-1375952","volume":"34","author":"PH Hayashi","year":"2014","unstructured":"Hayashi PH, Fontana RJ. Clinical features, diagnosis, and natural history of drug-induced liver injury. Semin Liver Dis. 2014;34(2):134\u2013144","journal-title":"Semin Liver Dis"},{"key":"9793_CR80","doi-asserted-by":"publisher","unstructured":"Andrade RJ, Lucena MI, Fernandez MC, et al. Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period. Gastroenterology 2005;129(2):512\u2013521","DOI":"10.1016\/j.gastro.2005.05.006"},{"issue":"2","key":"9793_CR81","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1002\/hep.23696","volume":"52","author":"RJ Fontana","year":"2010","unstructured":"Fontana RJ, Seeff LB, Andrade RJ, et al. Standardization of nomenclature and causality assessment in drug-induced liver injury: summary of a clinical research workshop. Hepatology. 2010;52(2):730\u2013742","journal-title":"Hepatology"},{"issue":"1","key":"9793_CR82","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1053\/j.gastro.2014.03.045","volume":"147","author":"RJ Fontana","year":"2014","unstructured":"Fontana RJ, Hayashi PH, Gu J, et al. Idiosyncratic drug-induced liver injury is associated with substantial morbidity and mortality within 6\u00a0months from onset. Gastroenterology. 2014;147(1):96\u2013108","journal-title":"Gastroenterology"},{"key":"9793_CR83","unstructured":"Borraz, Y, Fernandez MC, Garcia-Muhoz B, et al. Would it be desirable to modify the cut-off point for definition of chronicity in drug-induced liver injury (DILI)? In 61st Annual Meeting of the American Association for the Study of Liver Diseases; 2010. A270"},{"key":"9793_CR84","doi-asserted-by":"publisher","unstructured":"Robles-Diaz M, Lucena MI, Kaplowitz N, et al; Spanish DILI Registry; SLatinDILI Network; Safer and Faster Evidence-Based Translation Consortium. Use of Hy\u2019s law and a new composite algorithm to predict acute liver failure in patients with drug-induced liver injury. Gastroenterology 2014;147(1):109\u2013118","DOI":"10.1053\/j.gastro.2014.03.050"},{"issue":"1","key":"9793_CR85","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.mayocp.2013.09.016","volume":"89","author":"MD Leise","year":"2014","unstructured":"Leise MD, Poterucha JJ, Talwalkar JA. Drug-induced liver injury. Mayo Clin Proc. 2014;89(1):95\u2013106","journal-title":"Mayo Clin Proc"},{"issue":"1","key":"9793_CR86","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/j.1751-2980.2011.00552.x","volume":"13","author":"H Gao","year":"2012","unstructured":"Gao H, Li N, Wang JY, et al. Definitive diagnosis of hepatic sinusoidal obstruction syndrome induced by pyrrolizidine alkaloids. J Dig Dis. 2012;13(1):33\u201339","journal-title":"J Dig Dis"},{"issue":"4","key":"9793_CR87","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.jceh.2014.10.002","volume":"4","author":"CQ Fan","year":"2014","unstructured":"Fan CQ, Crawford JM. Sinusoidal obstruction syndrome\u00a0(hepatic veno-occlusive disease). J Clin Exp Hepatol. 2014;4(4):332\u2013346","journal-title":"J Clin Exp Hepatol"},{"issue":"1","key":"9793_CR88","first-page":"41","volume":"73","author":"AM Kootte","year":"2015","unstructured":"Kootte AM, Siegel AM, Koorenhof M. Generalised\u00a0peliosis hepatis\u00a0mimicking metastases after long-term use of oral contraceptives. Neth J Med. 2015;73(1):41\u201343","journal-title":"Neth J Med"},{"issue":"9","key":"9793_CR89","doi-asserted-by":"publisher","first-page":"2420","DOI":"10.3748\/wjg.v20.i9.2420","volume":"20","author":"CY Yu","year":"2014","unstructured":"Yu CY, Chang LC, Chen LW, et al. Peliosis hepatis\u00a0complicated by portal hypertension following renal transplantation. World J Gastroenterol. 2014;20(9):2420\u20132425","journal-title":"World J Gastroenterol"},{"issue":"4","key":"9793_CR90","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1053\/gast.2002.36061","volume":"123","author":"RM Green","year":"2002","unstructured":"Green RM, Flamm S. AGA technical review on the evaluation of liver chemistry tests. Gastroenterology. 2002;123(4):1367\u20131384","journal-title":"Gastroenterology"},{"key":"9793_CR91","doi-asserted-by":"publisher","unstructured":"Watkins PB, Desai M, Berkowitz SD, et al. Evaluation of drug-induced serious hepatotoxicity (eDISH): application of this data organization approach to phase III clinical trials of rivaroxaban after total hip or knee replacement surgery. Drug Saf 2011;(3)34:243\u2013252","DOI":"10.2165\/11586600-000000000-00000"},{"issue":"5","key":"9793_CR92","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1016\/j.jhep.2013.12.026","volume":"60","author":"A Eguchi","year":"2014","unstructured":"Eguchi A, Wree A, Feldstein AE. Biomarkers of liver cell death. J Hepatol. 2014;60(5):1063\u20131074","journal-title":"J Hepatol"},{"issue":"5","key":"9793_CR93","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1002\/hep.22633","volume":"48","author":"PB Watkins","year":"2008","unstructured":"Watkins PB, Seligman PJ, Pears JS, et al. Using controlled clinical trials to learn more about acute drug-induced liver injury. Hepatology. 2008;48(5):1680\u20131689","journal-title":"Hepatology"},{"issue":"1","key":"9793_CR94","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1002\/hep.23330","volume":"51","author":"RD Fannin","year":"2010","unstructured":"Fannin RD, Russo M, O\u2019Connell TM, et al. Acetaminophen dosing of humans results in blood transcriptome and metabolome changes consistent with impaired oxidative phosphorylation. Hepatology. 2010;51(1):227\u2013236","journal-title":"Hepatology"},{"issue":"5","key":"9793_CR95","doi-asserted-by":"publisher","first-page":"e37395","DOI":"10.1371\/journal.pone.0037395","volume":"7","author":"YW Su","year":"2012","unstructured":"Su YW, Chen X, Jiang ZZ, et al. A panel of serum microRNAs as specific biomarkers for diagnosis of compound- and herb-induced liver injury in rats. PLoS One. 2012;7(5):e37395","journal-title":"PLoS One"},{"issue":"5","key":"9793_CR96","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1002\/hep.25873","volume":"56","author":"S Bala","year":"2012","unstructured":"Bala S, Petrasek J, Mundkur S, et al. Circulating microRNAs in exosomes indicate hepatocyte injury and inflammation in alcoholic, drug-induced, and inflammatory liver diseases. Hepatology. 2012;56(5):1946\u20131957","journal-title":"Hepatology"},{"issue":"2","key":"9793_CR97","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1002\/hep.26294","volume":"58","author":"DJ Antoine","year":"2013","unstructured":"Antoine DJ, Dear JW, Lewis PS, et al. Mechanistic biomarkers provide early and sensitive detection of acetaminophen-induced acute liver injury at first presentation to hospital. Hepatology. 2013;58(2):777\u2013787","journal-title":"Hepatology"},{"key":"9793_CR98","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/B978-0-12-387817-5.00017-0","volume-title":"Drug-Induced Liver Disease","author":"PB Watkins","year":"2013","unstructured":"Watkins PB. Biomarkers for drug-induced liver injury. In: Kaplowitz N, Deleve LD, editors. Drug-Induced Liver Disease. 3rd ed. San Diego: Academic Press; 2013. 275\u2013286.","edition":"3"},{"key":"9793_CR99","doi-asserted-by":"crossref","unstructured":"Kenna JG. Current concepts in drug-induced bile salt export pump (BSEP) interference. Curr Protoc Toxicol 2014;61:23.7.1\u201323.7.15","DOI":"10.1002\/0471140856.tx2307s61"},{"issue":"4","key":"9793_CR100","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1097\/ACI.0000000000000070","volume":"4","author":"C Stephens","year":"2014","unstructured":"Stephens C, Andrade RJ, Lucena MI. Mechanisms of drug-induced liver injury. Curr Opin Allergy Clin Immunol. 2014;4(4):286\u2013292","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"4","key":"9793_CR101","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/j.jhep.2010.07.031","volume":"54","author":"G Lin","year":"2011","unstructured":"Lin G, Wang JY, Li N, et al. Hepatic sinusoidal obstruction syndrome associated with consumption of Gynura segetum. J Hepatol. 2011;54(4):666\u2013673","journal-title":"J Hepatol"},{"key":"9793_CR102","doi-asserted-by":"publisher","unstructured":"Vuppalanchi R, iangpunsakul S, Chalsani N. Etiology of new-onset jaundice: how often is it caused by idiosyncratic drug-induced liver injury in the United States. Am J Gastroenterol 2007;102(3):558\u2013562","DOI":"10.1111\/j.1572-0241.2006.01019.x"},{"issue":"10","key":"9793_CR103","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1136\/gut.2010.208413","volume":"59","author":"C Loras","year":"2010","unstructured":"Loras C, Gisber JP, Minguez M, et al. Liver dysfunction related to hepatitis B and C in patients with inflammatory bowel disease treated with immunosuppressive therapy. Gut. 2010;59(10):1340\u20131346","journal-title":"Gut"},{"issue":"1","key":"9793_CR104","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1002\/pds.1514","volume":"17","author":"GA Makar","year":"2008","unstructured":"Makar GA, Weiner MG, Kimmel SE, et al. Incidence and prevalence of abnormal liver associated enzymes in patients with atrial fibrillation in a routine clinical care population. Pharmacoepidemiol Drug Saf. 2008;17(1):43\u201351","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"6","key":"9793_CR105","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1038\/clpt.2011.58","volume":"89","author":"GP Aithal","year":"2011","unstructured":"Aithal GP, Watkins PB, Andrade RJ. Case definition and phenotype standardization in drug-induced liver injury. Clin Pharmacol Ther. 2011;89(6):806\u2013815","journal-title":"Clin Pharmacol Ther"},{"issue":"11","key":"9793_CR106","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1016\/0895-4356(93)90101-6","volume":"46","author":"G Danan","year":"1993","unstructured":"Danan G, Benichou C. Causality assessment of adverse reactions to drugs I. A novel method based on the conclusions of international consensus meetings: application to drug induced liver injuries. J Clin Epidemiol. 1993;46(11):1323\u20131330","journal-title":"J Clin Epidemiol"},{"key":"9793_CR107","unstructured":"http:\/\/livertox.nlm.nih.gov\/rucam.html . Accessed 28 Mar 2017"},{"issue":"1","key":"9793_CR108","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3390\/ijms17010014","volume":"17","author":"G Danan","year":"2016","unstructured":"Danan G, Teschke R. RUCAM\u00a0in\u00a0drug\u00a0and\u00a0herb\u00a0induced\u00a0liver\u00a0injury: the\u00a0update. Int J Mol Sci. 2016;17(1):14\u201346","journal-title":"Int J Mol Sci"},{"issue":"3","key":"9793_CR109","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1002\/hep.510260319","volume":"26","author":"VAJ Maria","year":"1997","unstructured":"Maria VAJ, Victorino RMM. Development and validation of a clinical scale for the diagnosis of drug induced hepatitis. Hepatology. 1997;26(3):664\u2013669","journal-title":"Hepatology"},{"issue":"1","key":"9793_CR110","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1053\/jhep.2001.20645","volume":"33","author":"MI Lucena","year":"2001","unstructured":"Lucena MI, Camargo R, Andrade RJ, et al. Comparison of two clinical scales for causality assessment in hepatotoxicity. Hepatology. 2001;33(1):123\u2013130","journal-title":"Hepatology"},{"key":"9793_CR111","doi-asserted-by":"publisher","unstructured":"Garc\u00eda-Cort\u00e9s\u00a0M, Lucena MI, Pachkoria K, et al. Evaluation of Naranjo adverse drug reactions probability scale in causality assessment of drug-induced liver injury. Aliment Pharmacol Ther 2008;27(9):780\u2013789","DOI":"10.1111\/j.1365-2036.2008.03655.x"},{"key":"9793_CR112","doi-asserted-by":"crossref","unstructured":". 2005;46(2):85\u201390 (articles in Japanese).","DOI":"10.1007\/BF01866614"},{"key":"9793_CR113","unstructured":"Hepatobiliary Diseases Cooperation Group of CSG. Recommendations for the diagnosis and treatment of acute drug-induced liver injury (draft). Chin J Dig 2007;27(11):765\u2013767 (articles in Chinese)."},{"issue":"6","key":"9793_CR114","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1002\/hep.23577","volume":"51","author":"DC Rockey","year":"2010","unstructured":"Rockey DC, Seeff LB, Rochon J, et al. Causality assessment in drug-induced liver injury using a structured expert opinion process: comparison to the Roussel\u2013Uclaf causality assessment method. Hepatology. 2010;51(6):2117\u20132126","journal-title":"Hepatology"},{"key":"9793_CR115","unstructured":"Research Group of Liver Failure and Artificial Liver; Society of Infectious Disease (SID); Chinese Medical Association (CMA); Research Group of Severe Liver Disease and Artificial Liver; Chinese Society of Hepatology (CSH); CMA. Guidelines for diagnosis and treatment of liver failure (2012 edition). Chin J Hepatol 2013;21(3):178\u2013179 (articles in Chinese)."},{"issue":"3","key":"9793_CR116","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1002\/hep.25551","volume":"55","author":"WM Lee","year":"2012","unstructured":"Lee WM, Stravitz RT, Larson AM. Introduction to the revised American Association for the study of liver diseases position paper on acute liver failure 2011. Hepatology. 2012;55(3):965\u2013967","journal-title":"Hepatology"},{"key":"9793_CR117","unstructured":"http:\/\/livertox.nlm.nih.gov\/Severity.html . \u00a0Accessed 28 Mar 2017"},{"issue":"10","key":"9793_CR118","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1016\/j.cgh.2009.06.027","volume":"7","author":"TN Palmore","year":"2009","unstructured":"Palmore TN, Shah NL, Loomba R, et al. Reactivation of hepatitis B with reappearance of hepatitis B surface antigen after chemotherapy and immunosuppression. Clin Gastroenterol Hepatol. 2009;7(10):1130\u20131137","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"9793_CR119","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1002\/hep.24481","volume":"54","author":"A Suzuki","year":"2011","unstructured":"Suzuki A, Brunt EM, Kleiner DE, et al. The use of liver biopsy evaluation in discrimination of idiopathic autoimmune hepatitis versus drug-induced liver injury. Hepatology. 2011;54(3):931\u2013939","journal-title":"Hepatology"},{"issue":"2\u20133","key":"9793_CR120","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1007\/s12016-014-8432-0","volume":"48","author":"Q Miao","year":"2015","unstructured":"Miao Q, Bian Z, Tang R, et al. Emperipolesis mediated by CD8 T cells is a characteristic histopathologic feature of autoimmune hepatitis. Clin Rev Allergy Immunol. 2015;48(2\u20133):226\u2013235","journal-title":"Clin Rev Allergy Immunol"},{"issue":"6","key":"9793_CR121","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.1002\/hep.23588","volume":"51","author":"E Bjornsson","year":"2010","unstructured":"Bjornsson E, Talwalkar J, Treeprasertsuk S, et al. Drug-induced autoimmune hepatitis: clinical characteristics and prognosis. Hepatology. 2010;51(6):2040\u20132048","journal-title":"Hepatology"},{"issue":"7","key":"9793_CR122","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1056\/NEJMra052270","volume":"354","author":"VJ Navarro","year":"2006","unstructured":"Navarro VJ, Senior JR. Drug-related hepatotoxicity. N Engl J Med. 2006;354(7):731\u2013739","journal-title":"N Engl J Med"},{"issue":"3","key":"9793_CR123","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1111\/jgh.12717","volume":"30","author":"S Wu","year":"2015","unstructured":"Wu S, Xia Y, Lv X, et al. Preventive use of\u00a0hepatoprotectors yields limited efficacy on the liver toxicity of anti-tuberculosis agents in a largecohort of\u00a0Chinese\u00a0patients. J Gastroenterol Hepatol. 2015;30(3):540\u2013545","journal-title":"J Gastroenterol Hepatol"},{"issue":"2","key":"9793_CR124","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.ejca.2008.10.031","volume":"45","author":"R Ford","year":"2009","unstructured":"Ford R, Schwartz L, Dancey J, US Food and Drug Administration; Center for Drug Evaluation and Research (CDER); Center for Biologics Evaluation and Research (CBER), et al. Guidance for industry: drug-induced liver injury\u2014premarketing clinical evaluation. Eur J Cancer. 2009;45(2):268\u2013274","journal-title":"Eur J Cancer"},{"issue":"3","key":"9793_CR125","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1056\/NEJMct0708278","volume":"359","author":"KJ Heard","year":"2008","unstructured":"Heard KJ. Acetylcysteine for acetaminophen poisoning. N Engl J Med. 2008;359(3):285\u2013292","journal-title":"N Engl J Med"},{"issue":"3","key":"9793_CR126","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1248\/bpb.34.366","volume":"34","author":"Y Masubuchi","year":"2011","unstructured":"Masubuchi Y, Nakayama J, Sadakata Y. Protective effects of exogenous glutathione and related thiol compounds against drug-induced liver injury. Biol Pharm Bull. 2011;34(3):366\u2013370","journal-title":"Biol Pharm Bull"},{"key":"9793_CR127","doi-asserted-by":"publisher","unstructured":"Berk M, Malhi GS, Gray LJ, et al. The promise of N-acetylcysteine in neuropsychiatry. Trends Pharmacol Sci 2013;34(3):167\u2013177","DOI":"10.1016\/j.tips.2013.01.001"},{"issue":"3","key":"9793_CR128","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1002\/hep.21075","volume":"43","author":"C Zwingmann","year":"2006","unstructured":"Zwingmann C, Bilodeau M. Metabolic insights into the hepatoprotective role of N-acetylcysteine in mouse liver. Hepatology. 2006;43(3):454\u2013463","journal-title":"Hepatology"},{"issue":"3","key":"9793_CR129","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1053\/j.gastro.2009.06.006","volume":"137","author":"WM Lee","year":"2009","unstructured":"Lee WM, Hynan LS, Rossaro L, et al. Intravenous N-acetylcysteine improves transplant-free survival in early stage non-acetaminophen acute liver failure. Gastroenterology. 2009;137(3):856\u2013864","journal-title":"Gastroenterology"},{"issue":"9918","key":"9793_CR130","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/S0140-6736(13)62062-0","volume":"383","author":"DN Bateman","year":"2014","unstructured":"Bateman DN, Dear JW, Thanacoody HK, et al. Reduction of adverse effects from intravenous acetylcysteine treatment for paracetamol poisoning: a randomized controlled trial. Lancet. 2014;383(9918):697\u2013704","journal-title":"Lancet"},{"issue":"5","key":"9793_CR131","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1007\/s10620-012-2512-x","volume":"58","author":"S Singh","year":"2013","unstructured":"Singh S, Hynan LS, Lee WM, Acute Liver Failure Study Group. Improvements in hepatic serological biomarkers are associated with clinical benefit of intravenous N-acetylcysteine in early stage non-acetaminophen acute liver failure. Dig Dis Sci. 2013;58(5):1397\u20131402","journal-title":"Dig Dis Sci"},{"key":"9793_CR132","unstructured":"Mao YM, Zeng MD, Chen Y, et al. Magnesium isoglycyrrhizinate in the treatment of chronic liver diseases: a randomized, double-blind, multi-doses, active drug controlled, multi-center study. Chin J Hepatol 2009;17(11):847\u2013851 (article in Chinese)"},{"issue":"4","key":"9793_CR133","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1177\/0300060514527058","volume":"42","author":"X Li","year":"2014","unstructured":"Li X, Zhou J, Chen S, et al. Role of bicyclol in preventing chemotherapeutic agent-induced liver injury in patients over 60\u00a0years of age with cancer. J Int Med Res. 2014;42(4):906\u2013914","journal-title":"J Int Med Res"},{"issue":"4","key":"9793_CR134","doi-asserted-by":"publisher","first-page":"475","DOI":"10.5588\/ijtld.14.0579","volume":"19","author":"NH Chu","year":"2015","unstructured":"Chu NH, Li L, Zhang X, et al. Role of bicyclol in preventing drug-induced liver injury in tuberculosis patients with liver disease. Int J Tuberc Lung Dis. 2015;19(4):475\u2013480","journal-title":"Int J Tuberc Lung Dis"},{"key":"9793_CR135","unstructured":"Zhang QH, Shi GF, Li Q. Effects of diammonium glycyrrhizinate enteric-coated capsule in the treatment of 2396 cases with chronic hepatitis. Chin J Infect Dis 2007;25(3):175\u2013176 (article in Chinese)"},{"issue":"10","key":"9793_CR136","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1002\/ptr.3207","volume":"24","author":"L Abenavoli","year":"2010","unstructured":"Abenavoli L, Capasso R, Milic N, et al. Milk thistle in\u00a0liver\u00a0diseases: past, present, future. Phytother Res. 2010;24(10):1423\u20131432","journal-title":"Phytother Res"},{"issue":"2","key":"9793_CR137","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.cld.2006.05.009","volume":"10","author":"RA Nathwani","year":"2006","unstructured":"Nathwani RA, Kaplowitz N. Drug hepatotoxicity. Clin Liver Dis. 2006;10(2):207\u2013217","journal-title":"Clin Liver Dis"},{"key":"9793_CR138","unstructured":"Ni LD, Xie Q, Li HW, et al. Ursodeoxycholic acid in the treatment of drug-injury: an open controlled clinical trial. Chin Hepatol 2009;14(4):278\u2013280 (article in Chinese)"},{"key":"9793_CR139","unstructured":"Zhao P, Duan GF, Du L, et al. Systematic evaluation on the efficacy of ademetionine in patients of drug-induced liver injury. Chin J Gastroenterol Hepatol 2011;20(4):341\u2013344 (article in Chinese)"},{"issue":"5","key":"9793_CR140","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1002\/hep.21650","volume":"45","author":"JM Mato","year":"2007","unstructured":"Mato JM, Lu SC. Role of S-adenosyl-l-methionine in liver health and injury. Hepatology. 2007;45(5):1306\u20131312","journal-title":"Hepatology"},{"issue":"3","key":"9793_CR141","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1517\/14740338.2011.562888","volume":"10","author":"B Vincenzi","year":"2011","unstructured":"Vincenzi B, Santini D, Frezza AM, et al. The role of S-adenosyl methionine in preventing FOLFOX-induced liver toxicity: a retrospective analysis in patients affected by resected colorectal cancer treated with adjuvant FOLFOX regimen. Expert Opin Drug Saf. 2011;10(3):345\u2013349","journal-title":"Expert Opin Drug Saf"},{"issue":"4","key":"9793_CR142","doi-asserted-by":"publisher","first-page":"439","DOI":"10.3109\/00365521.2014.958094","volume":"50","author":"R Jeong","year":"2015","unstructured":"Jeong R, Lee YS, Sohn C, et al. Model for end-stage liver disease score as a predictor of short-term outcome in patients with drug-induced liver injury. Scand J Gastroenterol. 2015;50(4):439\u2013446","journal-title":"Scand J Gastroenterol"},{"key":"9793_CR143","unstructured":"Yu YC, Chen CW. Interpretation of ACG clinical guidelines for the diagnosis and treatment of idiosyncratic drug-induced liver injury. Chin Hepatol 2014;19(8):570\u2013574 (article in Chinese)"},{"key":"9793_CR144","unstructured":"Zhang L, Yang XH. Phamacovigilance concept should be introduced sufficiently into the process of safety monitoring and evaluation of Chinese traditional medicine. Chin J Integr Tradit Western Med 2009;29(9):863\u2013866 (article in Chinese)"},{"issue":"10","key":"9793_CR145","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1007\/s40264-014-0222-3","volume":"37","author":"L Zhang","year":"2014","unstructured":"Zhang L, Wong LY, He Y, Wong IC. Pharmacovigilance in China: current situation, successes and challenges. Drug Saf. 2014;37(10):765\u2013770","journal-title":"Drug Saf"},{"key":"9793_CR146","first-page":"51530","volume-title":"Pharmacoepidemiology","author":"DJ Graham","year":"2005","unstructured":"Graham DJ, Mosholder AD, Gelperin K, et al. Pharmacoepidemiology and risk management. In: Strom BL, editor. Pharmacoepidemiology. 4th ed. West Sussex: Wiley; 2005. 51530.","edition":"4"},{"key":"9793_CR147","unstructured":"Olson S, Robinson S, Giffin R; Institute of Medicine. Accelerating the development of biomarkers for drug safety: workshop summary. National Academies Press. Ibid. Watkins PB, Bloom J, Hunt C. Biomarkers of Acute Idiosyncratic Hepatocellular Injury in Clinical Trials, Chap 5. 2009. 4257"},{"issue":"4","key":"9793_CR148","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1002\/pds.856","volume":"13","author":"M Willy","year":"2004","unstructured":"Willy M, Li Z. What is prescription labeling communicating to doctors about hepatotoxic drugs? A study of FDA-approved product labeling. Pharmacoepidemiol Drug Saf. 2004;13(4):201\u2013206","journal-title":"Pharmacoepidemiol Drug Saf"}],"container-title":["Hepatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12072-017-9793-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-017-9793-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-017-9793-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,5]],"date-time":"2020-10-05T06:32:19Z","timestamp":1601879539000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12072-017-9793-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,12]]},"references-count":148,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["9793"],"URL":"https:\/\/doi.org\/10.1007\/s12072-017-9793-2","relation":{},"ISSN":["1936-0533","1936-0541"],"issn-type":[{"value":"1936-0533","type":"print"},{"value":"1936-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,12]]}}}